The history of Viagra and its effect on the pharmaceutical sector presents a complex question regarding its continued attractiveness as an investment. Initially a phenomenal success, generating vast revenues, generic competition has substantially eroded financial returns. While major pharmaceutical firms maintain patents on related therapies and de

The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced substantial risk . Investors are now facing the effect of rival medications